Recro Pharma Inc. Common Stock
(NASDAQ:REPH)
Description
Recro Pharma, Inc., a contract development and manufacturing organization, engages in the development, manufacturing, and packaging of oral solid dose drug products in the United States and internationally. The company was formerly known as Recro Pharma I, Inc. and changed its name to Recro Pharma, Inc. in August 2008. Recro Pharma, Inc. was incorporated in 2007 and is based in Malvern, Pennsylvania.
REPH Overview
None
Sector |
Health Care |
Industry |
Major Pharmaceuticals |
Previous Close |
$3.7700 |
Previous Close Volume |
658148 |